To evaluate the anticancer (antiproliferative) activity of recombinant cIFN-α and commercial IFN-α2a, the inhibitory effect on hepatoma cell line HepG2 was studied using MTT colorimetric assay. This evidence concerns the gene IFNA2 and hepatocellular carcinoma.